Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
ES05 - Oncogenic Alterations and Beyond - Novel Treatments
- 12:00 - 13:00
- 8/07/2022
- Location: Hall C2
- IASLC CME Accredited
- Type: Education Session
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Caicun Zhou, Maximilian Johannes Hochmair
-
+
Session Moderator
12:00 - 12:00 | Presenter: Caicun Zhou
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Presenter: Maximilian Johannes Hochmair
- Abstract
Loading... -
+
ES05.01 - Session Introduction
12:00 - 12:01 | Presenter: Caicun Zhou
- Abstract
Loading... -
+
ES05.02 - Session Introduction
12:01 - 12:02 | Presenter: Maximilian Johannes Hochmair
- Abstract
Loading... -
+
ES05.03 - Targeting Rarer Events in Known Targets: EGFR Exon20 (EGFR, HER2)
12:02 - 12:14 | Presenter: Giannis Mountzios
- Abstract
Loading... -
+
ES05.04 - All You Need to Know About KRAS
12:14 - 12:26 | Presenter: Odd Terje Brustugun
- Abstract
Loading... -
+
ES05.05 - Antibody-Drug Conjugates - Where We Stand Today?
12:26 - 12:38 | Presenter: Bob T. Li
- Abstract
Loading... -
+
ES05.06 - HRD/DDR in Lung Cancer: Role and Therapeutic Implications
12:38 - 12:50 | Presenter: Lauren Averett Byers
- Abstract
Loading... -
+
ES05.07 - Live Q&A
12:50 - 13:00
- Abstract
Loading...
-
+
EP02.01 - Early Stage Non-small Cell Lung Cancer - Biomarkers
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Early Stage Non-small Cell Lung Cancer - Biomarkers
-
+
EP02.01-008 - Clinicopathological Features of Rare but Targetable Mutations in Surgically Resected Lung Carcinomas
Presenter: Luka Brcic- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-122 - Real-world Experience with Capmatinib in MET Exon 14-mutated Non-small Cell Lung Cancer (RECAP)
Presenter: Oliver Illini- Abstract
Loading...
-
+
EP16.01 - Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
-
+
EP16.01-015 - Introducing "BiomeOne" a Microbiome-based bBiomarker to Predict Immune Checkpoint Inhibitor Response in NSCLC 1patients
Presenter: Maximilian Johannes Hochmair- Abstract
Loading...
